Posts

Overcoming disruptions in the pharmaceutical supply chain 

We interviewed Datwyler’s Gabrielle Gehron to understand the best sourcing strat...

Otsuka and Astex’s oral Inaqovi wins European approval ...

European Commission has approved the oral combination drug for treating newly di...

60 Degrees pauses Phase IIB Covid-19 trial for tafenoquine

The company plans to refile the IND after assessing the feasibility of US FDA-su...

Pelican and Primordial Genetics merge to form biotech c...

Pelican Technology has combined business with Primordial Genetics under a deal t...

Orexo announces NDA submission to FDA for opioid overdo...

Orexo has submitted a new drug application (NDA) to the US FDA for its high-dose...

BioNTech and CEPI partner to develop Mpox vaccine

BioNTech has entered a strategic collaboration with the CEPI to develop mRNA-bas...

Pharmanovia announces acquisition of Sanofi’s CNS brands

UK-based Pharmanovia has announced the acquisition of 11 central nervous system ...

Risk adjusted net present value: What is the current va...

Puxitatug Samrotecan is a monoclonal antibody conjugated commercialized by Astra...

STAT+: Patients, doctors press FTC to beef up hospital ...

The FTC and DOJ got a flood of comments urging them to adopt their proposed merg...

STAT+: Pharmalittle: U.S. Chamber and feds clash on Med...

Chamber and government lawyers sparred over whether drugmakers have enough say i...

Opinion: Where are HHS and the FTC on online privacy fo...

Online services may be enormously beneficial for people with substance use disor...

STAT+: Medicare wants to increase payments for heart re...

Medicare plans to pay more for a type of cardiac rehabilitation that takes place...

Why doesn’t the U.S. have more Black midwives?

Advocates want to expand the use of midwives in childbirth and diversify the mid...

STAT+: David Liu startup to focus on getting CRISPR the...

A startup by prominent biochemist David Liu seeks to turn hollowed out viruses i...

STAT+: Johnson & Johnson is getting rid of its script l...

Johnson & Johnson will replace the well-known signature script in its logo with ...

An implantable device could enable injection-free contr...

CAMBRIDGE, MA — One promising approach to treating Type 1 diabetes is implanting...